Israeli stroke therapy co BrainQ raises $40m
The Jerusalem-based company's investigational cloud-based technology aims to reduce disability and promote rehabilitation neurorecovery for stroke victims.
Stay updated with breaking news from Dexcel Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Jerusalem-based company's investigational cloud-based technology aims to reduce disability and promote rehabilitation neurorecovery for stroke victims.
Periodontal Therapeutics Market Technology Development, Size, Share, Forecast & Future Trend Till 2027
April 1, 2021 By Bio-IT World Staff April 1, 2021 | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand. $969M Investment Fund for Early to Late-Stage Companies Foresite Capital, a multi-stage healthcare and life sciences investment firm, has announced its fifth and largest fundraise with $969 million in capital commitments, significantly oversubscribed above its original target. The offering comprises Foresite Capital Fund V, L.P. and Foresit...
AlleyWatch The immune system at its core is a complex system of cells, organs, and tissues. These components work in unison to fight infection in the form of microbes. Developing an understanding of how this intricate system works is critical in ensuring that society as a whole has adequate immune health to combat disease and infection. Immunai has built the largest database for immunology in the world using machine learning and AI to map the entire immune system at a granular and specific level. This data can be leveraged by the healthcare industry to provide better therapeutics that ...